Quarterly report · Q3
4521.TEDINET S100SS78
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥54.7bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥73.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥8.9bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥12.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥9.3bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥9.2bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥12.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥9.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥168.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥166.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥167.8bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥28.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥29.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥140.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥136.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥140.7bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥51.5bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥177.1 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.85 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.8 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥243.31 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.99 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 83.2% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E00935-000Medicinereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥52.9bn |
| jpcrp040300-q3r_E00935-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥52.9bn |
| jpcrp040300-q3r_E00935-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥7.9bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥54.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥54.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥8.9bn |
| jpcrp040300-q3r_E00935-000Medicinereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥53.8bn |
| jpcrp040300-q3r_E00935-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥53.8bn |
| jpcrp040300-q3r_E00935-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥11.4bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E00935-000Real Estatereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥960m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥55.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥55.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥12.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 380
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)一単元(100株)未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)科研製薬株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都文京区本駒込２－28－８ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |